Literature DB >> 32629518

Inflammatory Cell Infiltration of Adrenals in COVID-19.

Vsevolod A Zinserling1,2, Natalya Yu Semenova1,2, Alexander G Markov3, Oksana V Rybalchenko4, Jun Wang5, Roman N Rodionov6,7, Stefan R Bornstein5,8,9.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was originated in November-December 2019 in Wuhan, China, and has rapidly spread around the world causing severe health and socioeconomical damage to the entire civilization. The key feature of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is upper respiratory tract infection, which may be complicated by bilateral pneumonia. Angiotensin converting enzyme 2 (ACE2) has been identified as a key host factor, required for virus entry into cells. Interestingly, ACE2 is expressed not only in the respiratory system, but also in the other organs and systems including adrenal glands. Here we provide the first description of the pathomorphological changes in adrenal glands in patients with severe COVID-19 characterized by perivascular infiltration of CD3+ and CD8+ T-lymphocytes. Due to the central role of the adrenals in the stress response of the organism, this finding is of potential clinical relevance, because infection with the SARS-CoV-2 virus might critically impair adrenal function under pathophysiological conditions. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2020        PMID: 32629518     DOI: 10.1055/a-1191-8094

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  14 in total

1.  SARS-CoV-2-Induced Pathology-Relevance to COVID-19 Pathophysiology.

Authors:  Vsevolod A Zinserling; Natalia Yu Semenova; Anastasia E Bikmurzina; Natalia M Kruglova; Oksana V Rybalchenko; Alexander G Markov
Journal:  Pathophysiology       Date:  2022-06-10

Review 2.  The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism.

Authors:  Abdolkarim Mahrooz; Giovanna Muscogiuri; Raffaella Buzzetti; Ernesto Maddaloni
Journal:  Endocrine       Date:  2021-04-22       Impact factor: 3.633

Review 3.  COVID-19-A Theory of Autoimmunity Against ACE-2 Explained.

Authors:  Philip McMillan; Thomas Dexhiemer; Richard R Neubig; Bruce D Uhal
Journal:  Front Immunol       Date:  2021-03-23       Impact factor: 7.561

4.  Adrenal haemorrhage as a complication of COVID-19 infection.

Authors:  Noor Sharrack; Conal Thomas Baxter; Michael Paddock; Elizabeth Uchegbu
Journal:  BMJ Case Rep       Date:  2020-11-30

Review 5.  Adrenal Insufficiency in Coronavirus Disease 2019 (COVID-19)-Infected Patients without Preexisting Adrenal Diseases: A Systematic Literature Review.

Authors:  Mehrbod Vakhshoori; Maryam Heidarpour; Niloofar Bondariyan; Niyousha Sadeghpour; Zohreh Mousavi
Journal:  Int J Endocrinol       Date:  2021-09-14       Impact factor: 3.257

Review 6.  COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.

Authors:  Zoltán Szekanecz; Attila Balog; Tamás Constantin; László Czirják; Pál Géher; László Kovács; Gábor Kumánovics; György Nagy; Éva Rákóczi; Szilvia Szamosi; Gabriella Szűcs; István Vályi-Nagy
Journal:  Expert Rev Mol Med       Date:  2022-03-15       Impact factor: 5.600

7.  Changes in Physiological Levels of Cortisol and Adrenocorticotropic Hormone upon Hospitalization Can Predict SARS-CoV-2 Mortality: A Cohort Study.

Authors:  Iraj Ahmadi; Hamideh Estabraghnia Babaki; Maryam Maleki; Hashem Jarineshin; Mohammad Reza Kaffashian; Mehdi Hassaniazad; Azra Kenarkoohi; Amin Ghanbarnejad; Shahab Falahi; Mitra Kazemi Jahromi; Hori Ghaneialvar; Shahla Sohrabipour
Journal:  Int J Endocrinol       Date:  2022-02-25       Impact factor: 3.257

8.  Metabolic Syndrome and COVID-19: Endocrine-Immune Vascular Interactions Shape the Clinical Course.

Authors:  Andreas Barthel; Karthikeyan Mohanraj; Anne Marie Biener; Stefan R Bornstein
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

9.  Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations.

Authors:  George P Chrousos; Petros P Sfikakis; Maria P Yavropoulou; Maria G Filippa; Aimilia Mantzou; Fotinie Ntziora; Maria Mylona; Maria G Tektonidou; Nikolaos I Vlachogiannis; Dimitrios Paraskevis; Gregory A Kaltsas
Journal:  Endocrine       Date:  2022-01-18       Impact factor: 3.633

10.  Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19.

Authors:  Tanja Paul; Stephan Ledderose; Harald Bartsch; Na Sun; Sarah Soliman; Bruno Märkl; Viktoria Ruf; Jochen Herms; Marcel Stern; Oliver T Keppler; Claire Delbridge; Susanna Müller; Guido Piontek; Yuki Schneider Kimoto; Franziska Schreiber; Tracy Ann Williams; Jens Neumann; Thomas Knösel; Heiko Schulz; Ria Spallek; Matthias Graw; Thomas Kirchner; Axel Walch; Martina Rudelius
Journal:  Nat Commun       Date:  2022-03-24       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.